GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Shandong Jincheng Pharmaceutical Group Co Ltd (SZSE:300233) » Definitions » EV-to-EBIT

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) EV-to-EBIT : 20.68 (As of May. 28, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Jincheng Pharmaceutical Group Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Shandong Jincheng Pharmaceutical Group Co's Enterprise Value is ¥6,078 Mil. Shandong Jincheng Pharmaceutical Group Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥294 Mil. Therefore, Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT for today is 20.68.

The historical rank and industry rank for Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT or its related term are showing as below:

SZSE:300233' s EV-to-EBIT Range Over the Past 10 Years
Min: -32.42   Med: 26.1   Max: 153.15
Current: 20.58

During the past 13 years, the highest EV-to-EBIT of Shandong Jincheng Pharmaceutical Group Co was 153.15. The lowest was -32.42. And the median was 26.10.

SZSE:300233's EV-to-EBIT is ranked worse than
56.05% of 1231 companies
in the Chemicals industry
Industry Median: 17.88 vs SZSE:300233: 20.58

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Shandong Jincheng Pharmaceutical Group Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥5,568 Mil. Shandong Jincheng Pharmaceutical Group Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥294 Mil. Shandong Jincheng Pharmaceutical Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.28%.


Shandong Jincheng Pharmaceutical Group Co EV-to-EBIT Historical Data

The historical data trend for Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Jincheng Pharmaceutical Group Co EV-to-EBIT Chart

Shandong Jincheng Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.32 -17.58 49.14 23.24 23.94

Shandong Jincheng Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.34 30.23 31.08 23.94 18.95

Competitive Comparison of Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT

For the Chemicals subindustry, Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT falls into.



Shandong Jincheng Pharmaceutical Group Co EV-to-EBIT Calculation

Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6077.528/293.826
=20.68

Shandong Jincheng Pharmaceutical Group Co's current Enterprise Value is ¥6,078 Mil.
Shandong Jincheng Pharmaceutical Group Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥294 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Jincheng Pharmaceutical Group Co  (SZSE:300233) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Shandong Jincheng Pharmaceutical Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=293.826/5568.36225
=5.28 %

Shandong Jincheng Pharmaceutical Group Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥5,568 Mil.
Shandong Jincheng Pharmaceutical Group Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥294 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Jincheng Pharmaceutical Group Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Shandong Jincheng Pharmaceutical Group Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Shuangshan Road, Zichuan Economic Development Zone, Shandong, Zibo, CHN, 255100
Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.
Executives
Yang Xiu Liang Executives
Zhang Xue Bo Director
Zheng Geng Xiu Director
Zhao Ye Qing Director
Sun Rui Mei Executives
Cui Xi Li Executives
Zhao Hong Fu Director
Fu Miao Qing Executives
Zhu Xiao Gang Directors, executives
Li Jia Quan Directors, executives
Guo Fang Shui Supervisors
Chou Qiang Securities Affairs Representative

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Headlines

No Headlines